SLC6A19

SLC6A19 encodes B0AT1, the principal apical sodium-dependent neutral amino acid transporter in intestinal enterocytes and renal proximal tubule epithelium, whose loss-of-function mutations cause Hartnup disorder (PMID:15286787, PMID:15286788). B0AT1 co-transports one Na+ per neutral amino acid in an electrogenic, chloride-independent cycle with a random or ordered binding mechanism, preferring large non-aromatic neutral amino acids (PMID:15804236, PMID:16133263). Surface expression of B0AT1 is obligatorily dependent on the ancillary proteins ACE2 in the intestine and collectrin (TMEM27) in the kidney, which also modulate catalytic activity; the transporter forms a functional heterodimeric unit with ACE2 that further associates with aminopeptidase N to increase apparent substrate affinity, while kinases SGK1-3 and PKB/Akt–PIKfyve promote membrane insertion (PMID:19472175, PMID:26240152, PMID:22677001, PMID:20511718, PMID:23234856). Beyond epithelial amino acid absorption, B0AT1-mediated tryptophan uptake feeds de novo NAD+ biosynthesis to activate SIRT1-dependent chromatin regulation, and whole-body B0AT1 deficiency impairs mTOR signaling and insulin secretion, linking apical amino acid transport to systemic metabolic homeostasis (PMID:21636576, PMID:41203631).

1. 2004 High

   Identification of SLC6A19 as the gene encoding the long-sought epithelial system B0 neutral amino acid transporter resolved the molecular basis of Hartnup disorder and established the gene's primary physiological role in intestinal and renal amino acid absorption.

   Evidence Homozygosity mapping and gene cloning in Hartnup families combined with in vitro transport assays of disease-causing mutations

   PMID:15286787 PMID:15286788

   Open questions at the time

   • Three-dimensional structure of B0AT1 not determined
   • Mechanism of tissue-specific expression not addressed
   • Ancillary protein requirements not yet identified
2. 2005 High

   Detailed electrophysiological characterization established the fundamental transport mechanism — 1:1 Na+:amino acid stoichiometry, electrogenic translocation, voltage dependence, and substrate preference for large neutral amino acids — providing the biophysical framework for all subsequent functional studies.

   Evidence Two-electrode voltage-clamp and simultaneous radiolabeled substrate uptake in Xenopus oocytes with kinetic modeling

   PMID:15804236 PMID:16133263

   Open questions at the time

   • Structural basis of substrate selectivity unknown
   • Ion coupling mechanism at the atomic level unresolved
3. 2009 High

   Recognition that B0AT1 requires tissue-specific ancillary proteins — collectrin in the kidney and ACE2 in the intestine — for plasma membrane trafficking explained how a single transporter achieves regulated surface expression in two distinct epithelia.

   Evidence Multiple experimental studies showing loss of surface expression in the absence of collectrin or ACE2, consolidated in a review

   PMID:19472175

   Open questions at the time

   • Molecular interface between B0AT1 and ancillary proteins not mapped
   • Whether ancillary proteins modulate catalytic activity beyond trafficking not resolved
4. 2010 High

   Identification of SGK1-3, PKB/Akt–PIKfyve, and JAK2 as kinases that stimulate B0AT1 surface abundance via enhanced membrane insertion revealed a signaling-regulated layer of transporter control beyond the obligatory ancillary protein requirement.

   Evidence Voltage-clamp, surface protein quantification, and brefeldin A chase in Xenopus oocytes co-expressing kinase-active versus kinase-dead constructs

   PMID:20511718 PMID:21964291 PMID:23234856

   Open questions at the time

   • Direct phosphorylation site(s) on B0AT1 not identified
   • In vivo relevance of kinase regulation not tested in animal models
   • Whether kinase effects operate through collectrin/ACE2 or independently unknown
5. 2011 High

   The Slc6a19-knockout mouse demonstrated that B0AT1 is essential for intestinal and renal neutral amino acid absorption in vivo and linked transporter loss to blunted postprandial insulin secretion, reduced mTOR signaling, and activated amino acid starvation responses, connecting epithelial transport to systemic metabolic signaling.

   Evidence Slc6a19 knockout mice with brush-border membrane vesicle transport assays, mTOR/GCN2/ATF4 pathway Western blots, and insulin measurements

   PMID:21636576

   Open questions at the time

   • Whether metabolic phenotypes are secondary to intestinal versus renal transport loss not dissected
   • Contribution of individual amino acids (e.g., tryptophan vs. leucine) to signaling phenotypes not resolved
6. 2012 High

   Demonstration that B0AT1 forms a ternary brush-border complex with ACE2 and aminopeptidase N, with APN catalytic activity increasing B0AT1 substrate affinity by local substrate concentration, established a digestive-absorptive supramolecular unit on the enterocyte surface.

   Evidence Co-immunoprecipitation from native brush-border membranes, blue native electrophoresis, Xenopus oocyte co-expression with APN mutagenesis and peptide competition

   PMID:22677001

   Open questions at the time

   • Stoichiometry of the ternary complex not determined
   • How the complex is assembled during biosynthetic trafficking unknown
7. 2013 High

   Multi-level transcriptional control of Slc6a19 by promoter CpG methylation, histone H3K27 acetylation, and opposing transcription factors HNF1α/HNF4α (activating) versus SOX9 (repressing) explained the crypt-to-villus gradient of B0AT1 expression and established the epigenetic logic of its tissue-restricted transcription.

   Evidence Enterocyte/crypt fractionation with ChIP, promoter methylation, and gene expression analysis

   PMID:24121511

   Open questions at the time

   • Whether these regulatory mechanisms are conserved in human intestine not shown
   • Upstream signals triggering demethylation during enterocyte differentiation unknown
8. 2015 High

   Systematic mutagenesis revealed that collectrin is required not only for B0AT1 surface trafficking but also for catalytic activation, and identified transmembrane domains 1α, 5, and 7 as critical interaction interfaces, while syntaxin 1A/3 compete with collectrin to restrict surface expression.

   Evidence Fusion constructs and TM-domain mutagenesis of B0AT1/B0AT3 with electrophysiological assay in Xenopus oocytes

   PMID:26240152

   Open questions at the time

   • High-resolution structural basis of collectrin–B0AT1 interface not determined
   • Whether syntaxin competition is physiologically regulated unknown
9. 2021 Medium

   Radiation inactivation analysis of native enterocyte membranes demonstrated that the ACE2:B0AT1 heterodimer (~184 kDa) is the minimal functional transport unit within a larger dimer-of-heterodimers quaternary assembly, reconciling structural and functional data.

   Evidence Radiation inactivation of purified brush-border membrane vesicles with target size theory analysis

   PMID:34847569

   Open questions at the time

   • Result from a single biophysical approach; independent validation by cryo-EM functional reconstitution lacking
   • Whether the dimer-of-heterodimers displays cooperativity not tested
10. 2022 Medium

    Characterization of Hartnup-causing missense variants showed that most are retained in the ER, and specific variants (R178Q, S303L) also trap ACE2 intracellularly, revealing that mutant B0AT1 can dominantly impair its trafficking partner.

    Evidence Subcellular localization by immunofluorescence and biochemical fractionation of 18 B0AT1 variants in cell lines

    PMID:40852587

    Open questions at the time

    • Whether ACE2 mislocalization contributes to disease phenotype in patients not tested
    • Rescue by chemical chaperones not explored
11. 2022 Medium

    Detection of B0AT1 and ACE2 in mouse preimplantation embryos and reduced litter size in Slc6a19-knockout mice extended the transporter's known physiological roles beyond adult epithelia to early embryonic development and proline uptake at the 4–8 cell stage.

    Evidence Slc6a19 knockout mice, radiolabeled proline uptake in oocytes and embryos, in vitro embryo culture

    PMID:36611813

    Open questions at the time

    • Mechanism by which proline uptake supports preimplantation development not established
    • Whether human embryos depend on B0AT1 at equivalent stages unknown
12. 2025 Medium

    A tryptophan→NAD+→SIRT1→H3K27 deacetylation axis downstream of B0AT1 transport was delineated in renal cell carcinoma, linking the transporter to chromatin regulation and epithelial-mesenchymal transition suppression, and broadening its function beyond nutrient absorption to metabolic-epigenetic signaling.

    Evidence SLC6A19 overexpression/knockdown in RCC cell lines and xenograft models with NAD+ quantification, SIRT1 activity assays, H3K27Ac ChIP, and EMT marker analysis

    PMID:41203631

    Open questions at the time

    • Whether this NAD+–SIRT1 axis operates in normal renal tubular cells not tested
    • Specificity of B0AT1 versus other tryptophan transporters in this context not established
    • In vivo validation in non-cancer physiological settings lacking

• Major unresolved questions include the high-resolution structural basis of B0AT1 interaction with collectrin and ACE2 in transport-active states, the identity of direct phosphorylation sites mediating kinase regulation, tissue-specific dissection of intestinal versus renal contributions to systemic metabolic phenotypes, and whether the NAD+–SIRT1 chromatin pathway operates in normal epithelial physiology.
• No experimental B0AT1 structure in transport cycle intermediates
• Direct kinase phosphorylation sites on B0AT1 not mapped
• Conditional tissue-specific knockouts not reported